Stocks · News reference

8-K filing — Jaguar Health, Inc. (JAGX)

Sep 4, 2026, 8:15 PMSEC EDGAR

Filed: 2026-09-04 AccNo: 0001193125-26-383673 Size: 141 KB Item 8.01: Other Events

Read original source More stocks news

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source: edgar
Observed: Sep 4, 2026, 8:15 PM
Checked: Sep 4, 2026, 8:15 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaSep 4, 2026, 2:36 PMBenzinga Newsdesk
Jaguar Health shares are trading lower. The company announced its Napo unit provided crofelemer for treatment of congenital sodium diarrhea in an infant and said it plans to file for FDA approval for MVID in 2027.
Read original at benzinga
JAGX
BenzingaSep 4, 2026, 12:32 PMBenzinga Newsdesk
Jaguar Health Says Napo Unit Providing Crofelemer Oral Solution For Compassionate Use In Infant With Intestinal Failure From Congenital Sodium Diarrhea; Plans Mid-2027 NDA Filing For Crofelemer In MVID
Read original at benzinga
JAGX
BenzingaAug 26, 2026, 1:10 PMBenzinga Newsdesk
Jaguar Health Initiates Commercial Roll Out Of Neonorm Dog
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the initiation of the commercial launch of Neonorm Dog, a new extension of Jaguar's Neonorm franchise for companion and production animals.
Read original at benzinga
JAGX